Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-54.28%Return on Equity
VS
Market
Sector
Industry
History
$ 17.47Close
$ 6.87 - $ 17.96 52-Week Range
Ticker Information
Ticker
RCUSCompany Name
ARCUS BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEARCUS BIOSCIENCES INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RCUS - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 549M | $ -298M | -54.28% |
| 3/31/2025 | $ 531M | $ -391M | -73.63% |
| 12/31/2024 | $ 485M | $ -283M | -58.35% |
| 9/30/2024 | $ 565M | $ -270M | -47.79% |
| 6/30/2024 | $ 635M | $ -249M | -39.21% |
| 3/31/2024 | $ 707M | $ -231M | -32.67% |
| 12/31/2023 | $ 462M | $ -307M | -66.45% |
| 9/30/2023 | $ 520M | $ -293.46M | -56.43% |
| 6/30/2023 | $ 566M | $ -287.38M | -50.77% |
| 3/31/2023 | $ 600M | $ -279.01M | -46.5% |
Key Performance Insights, Last 5 Years
- ARCUS BIOSCIENCES INC's latest trailing twelve months (TTM) ROE stands at -16.09%.
- Over the past 5 years, ARCUS BIOSCIENCES INC's average ROE has been -34.14%.
- The median ROE for ARCUS BIOSCIENCES INC during this period was -39.93%
- ARCUS BIOSCIENCES INC reached its highest ROE over the past 5 years at 11.42%.
- The lowest ROE recorded by ARCUS BIOSCIENCES INC in the same timeframe -73.63%
ARCUS BIOSCIENCES INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ARCUS BIOSCIENCES INC is calculated as follows: Net Inc. Cmn. [ $ -87.6M ] / Equity [ $ 544.42M ]
(=) ROE [ -16.09% ] RCUS - Return on Equity, Last 5 years
-73.63%
Minimum
Mar 31, 2025
11.42%
Maximum
Sep 30, 2022
-34.14%
Average
-39.93%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |